ARGFX
Price
$75.74
Change
-$0.79 (-1.03%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

ARGFX vs VMVAX

Header iconARGFX vs VMVAX Comparison
Open Charts ARGFX vs VMVAXBanner chart's image
Ariel Fund Investor
Price$75.74
Change-$0.79 (-1.03%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ARGFX vs VMVAX Comparison Chart
Loading...
VS
ARGFX vs. VMVAX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGFX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. ARGFX (2.78B). VMVAX pays higher dividends than ARGFX: VMVAX (2.14) vs ARGFX (0.38). ARGFX was incepted earlier than VMVAX: ARGFX (38 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. ARGFX (20.00). ARGFX has a lower initial minimum investment than VMVAX: ARGFX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. ARGFX (19.39). VMVAX return over 5 years is better than : 48.82 vs. ARGFX (20.57).
ARGFXVMVAXARGFX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence38 years13 years-
Gain YTD10.89314.94673%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets2.78B30.5B9%
Annual Yield % from dividends0.382.1418%
Returns for 1 year19.3925.3576%
Returns for 3 years-9.3320.71-45%
Returns for 5 years20.5748.8242%
Returns for 10 years5.14100.885%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio